Delivery Order SPE2DR25D2005-SPE2DR26FE6D1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,274.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order, issued on November 4, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's critical role in supporting...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,571.73 for M-M-R II vaccine vials on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value transaction under AmerisourceBergen's existing relationship with the federal government's medical supply chain. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,763.46 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract utilizing the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,371.44 for M-M-R II vaccine vials, with an ultimate completion date of May 13, 2025. This firm fixed-price contract, awarded on May 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-competitive and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,526.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $17,531.26 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of October 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical supplier for...
- The Defense Logistics Agency awarded a $11,180.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 26, 2025. This non-set-aside contract was awarded competitively on September 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency (DLA) awarded a $12,923.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 26, 2025, with an ultimate completion date of September 29, 2025. This competitively awarded contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6D1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, processed without a set-aside designation, represents a competitive procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including vaccines, to support military healthcare systems worldwide. The current delivery order for M-M-R II vaccine vials reflects the company's ongoing role as a critical vendor for federal medical procurement needs, particularly supporting Defense Health Agency and military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/4/25 |